Targeted metabolomics workflow

Accurately quantify specific metabolites with our targeted metabolomics approach. Metabolites can be derived from untargeted discovery experiments or from data generated through hypothesis-driven research.

 

Our mass spectrometers are essential instruments for targeted metabolomics, facilitating high-throughput, highly sensitive, and selective workflows, making them a powerful tool in any research setting. The novel Thermo Scientific Stellar Mass Spectrometer accelerates method development and allows for precise quantification of a large number of target metabolites. This is crucial for hypothesis-driven experiments and is instrumental in bridging the gap between initial discovery and validation by verifying putative metabolite markers.

 

Streamline workflows and enhance data accuracy with Stellar MS advanced features, which enable you to drive forward metabolomics research with greater efficiency and confidence.


What you get from our targeted metabolomics platform

Pair advanced separation techniques with Stellar Mass Spectrometer to bridge the gap between discovery and validation by verifying putative metabolite markers. Enhanced scan speed and sensitivity enable deep and precise quantitation of numerous metabolites targets using rapid gradients, accommodating larger sample sizes with swift turnaround times.

 

Ensure a smooth transition from discovery to validation phases for all potential biomarkers, accelerating the translation of metabolomic findings into actionable insights for precision medicine, diagnostics, and therapeutic interventions.


Expanded Scale

The Stellar Mass Spectrometer expands experimental scale, permitting quantitative characterization of large number of metabolite targets in one experiment enabling high throughput needed to evaluate systems biology.

The bar charts show the number of monitored lipids, with the minimum of 3 points per peak defined, in positive and negative mode with a 4 minute HILIC gradient.

High sensitivity

To gain a complete insight into their biological condition, metabolomics studies measure a wide range of endogenous metabolite levels. Targeted methods on Stellar MS allow for the quantification of extremely low femtomole concentrations, offering a linear dynamic range spanning up to five orders of magnitude with accurate coefficients of variation (CV).

PRM-based experiments were conducted to quantify bile acids in the mice's fecal samples, aiming for increased annotation rates and accurate quantitation. The RP-LC based method exhibited high sensitivity (LLOQ 12.7 femtomoles on the column for most analyzed bile acids) and a linear dynamic range spanning 5 orders of magnitude.

Specificity

For accurate biomarker measurement, high sensitivity and specificity is crucial to ensure that detected signals corresponds to the target analytes. MS3 acquisition effectively minimizes background noise and enhances specificity, especially for distinguishing isomeric compounds in complex samples. The Stellar Mass Spectrometer excels with its rapid tMS3 acquisition speeds of up to 40 Hz and automated method setup. This advanced tMS3 acquisition improves detection limits (LOD) and quantitation limits (LOQ), allowing for the simultaneous quantification of multiple analytes in a single spectrum, even with fast UHPLC gradients.

Illustration of the capabilities of the Stellar Mass Spectrometer, showcasing rapid MS2 level fragmentation (up to 140 Hz) to enhance the selectivity of co-eluting isomers and efficient MS3 level fragmentation. Initially, chromatographic separation of bile acid isomers GCDCA and GDCA necessitated ion-pairing reagents (A). However, reducing additives and flow rates led to co-elution of the isomers (B) precluding gradient shortening. MS2 fragmentation generated similar patterns (C), impeding PRM quantitation. Yet, the instrument's MSn capability facilitated the detection of diagnostic ions for each isomer, enabling accurate quantitation in high-throughput analyses without ion-pairing reagents or high solvent flow rates (D).

Throughput

The Stellar Mass Spectrometer makes it possible to accelerate biomarker verification, while maintaining analyte capacity, sensitivity, selectivity, and specificity.

Fecal metabolites from the MetaSci library were quantified using the Stellar Mass Spectrometer after separation with reversed-phase, HILIC, and mixed-mode columns. Using gradients under 25 minutes, all methods showed high sensitivity and a wide linear dynamic range over five orders of magnitude with tMS2 quantitation, maintaining peak quality. Base peak chromatograms of positive and negative ion modes of bovine heart lipid extract (1 μg on column) in a single run.

Targeted metabolomics workflow

Accurate and reproducible metabolite quantitation

 

Experience significantly enhanced biomarker verification through advanced mass spectrometry capabilities and a robust targeted metabolomics workflow. With our targeted metabolomics workflow, you may:

  • Accurately measure the concentrations of predefined metabolites within a sample
  • Identify and validate biomarkers for disease diagnosis, prognosis, and therapeutic monitoring
  • Investigate specific metabolic pathways and their alterations in different biological conditions
  • Process a large number of samples efficiently, which is ideas for large-scale studies

SRM analysis on Thermo Scientific TSQ Triple Quadrupole Mass Spectrometers is the benchmark for targeted metabolomics. For targeted lists of known, well-characterized metabolites and compounds, TSQ Triple Quadrupole Mass Spectrometers offer sensitive, fast, and robust quantitation of metabolites.

 

For remarkable sensitivity and broad compound coverage, Stellar MS integrates the quantitative power of triple quadrupole technology with the rapid full-scan MSn acquisition capabilities of dual-pressure linear ion trap technology. Ideal for large-scale studies, Stellar MS enables high-throughput targeted quantitation workflow without compromising data quality. The proficiency in handling complex sample matrices ensures precise and efficient method development. Additionally, high scan speed and sensitivity facilitate deep and accurate quantitation, allowing for faster analysis and larger sample sizes. The seamless transition from discovery to validation phases accelerates the translation of metabolomic findings into actionable insights for precision medicine, diagnostics, and therapeutic interventions, positioning the Stellar MS as an indispensable tool in the field of metabolomics.

 

Alternatively, the AbsoluteIDQ® p400 HR kit, the first standardized solution for broad targeted metabolic profiling developed and verified for use with Orbitrap mass spectrometers, covers key metabolites relevant to pathophysiological processes and disease specific markers. This workflow delivers quantification of hundreds of metabolites with high throughput and the reproducibility needed for rigorous and confident results.


What customers are saying about the Stellar MS

“This is a step forward towards “omics-scale” quantitative MS-based methodology for an in-depth investigation of metabolism.”

 

Julijana Ivanisevic, PhD, Principal Investigator, Université de Lausanne


For Research Use Only. Not for use in diagnostic procedures.